Lung cancer molecular mutations and abnormal glycosylation as biomarkers for early diagnosis

MLA

Mingming Xu, et al. “Lung Cancer Molecular Mutations and Abnormal Glycosylation as Biomarkers for Early Diagnosis.” Cancer Treatment and Research Communications, vol. 27, Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....58d4d1e929cbe1c8cf17f07b564172cb&authtype=sso&custid=ns315887.

APA

Mingming Xu, Zeren Yang, Jun Xia, Shuang Yang, & Shuwei Li. (2020). Lung cancer molecular mutations and abnormal glycosylation as biomarkers for early diagnosis. Cancer Treatment and Research Communications, 27.

Chicago

Mingming Xu, Zeren Yang, Jun Xia, Shuang Yang, and Shuwei Li. 2020. “Lung Cancer Molecular Mutations and Abnormal Glycosylation as Biomarkers for Early Diagnosis.” Cancer Treatment and Research Communications 27 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....58d4d1e929cbe1c8cf17f07b564172cb&authtype=sso&custid=ns315887.